Lupin Limited (LUPIN) - Total Liabilities
Based on the latest financial reports, Lupin Limited (LUPIN) has total liabilities worth Rs137.72 Billion INR (≈ $1.49 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Lupin Limited (LUPIN) net asset momentum to track the company's year-over-year net asset growth rate.
Lupin Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Lupin Limited's total liabilities have evolved over time, based on quarterly financial data. See LUPIN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Lupin Limited Competitors by Total Liabilities
The table below lists competitors of Lupin Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KERRY GRP PLC ADR/1EO-12
F:KRZA
|
Germany | €4.72 Billion |
|
Aptiv PLC
NYSE:APTV
|
USA | $15.68 Billion |
|
James Hardie Industries PLC ADR
NYSE:JHX
|
USA | $7.41 Billion |
|
Logitech International S.A.
SW:LOGN
|
Switzerland | CHF1.64 Billion |
|
Far EasTone Telecommunications Co Ltd
TW:4904
|
Taiwan | NT$85.18 Billion |
|
Applied Industrial Technologies
NYSE:AIT
|
USA | $1.13 Billion |
|
United Spirits Limited
NSE:MCDOWELL-N
|
India | Rs50.76 Billion |
|
Corebridge Financial Inc.
NYSE:CRBG
|
USA | $369.86 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Lupin Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LUPIN market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.28 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lupin Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lupin Limited (2004–2025)
The table below shows the annual total liabilities of Lupin Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs119.11 Billion ≈ $1.29 Billion |
+23.76% |
| 2024-03-31 | Rs96.24 Billion ≈ $1.04 Billion |
-7.58% |
| 2023-03-31 | Rs104.13 Billion ≈ $1.13 Billion |
+8.48% |
| 2022-03-31 | Rs95.99 Billion ≈ $1.04 Billion |
-1.57% |
| 2021-03-31 | Rs97.52 Billion ≈ $1.05 Billion |
-21.37% |
| 2020-03-31 | Rs124.03 Billion ≈ $1.34 Billion |
-12.41% |
| 2019-03-31 | Rs141.60 Billion ≈ $1.53 Billion |
+11.60% |
| 2018-03-31 | Rs126.88 Billion ≈ $1.37 Billion |
-2.96% |
| 2017-03-31 | Rs130.75 Billion ≈ $1.41 Billion |
+14.40% |
| 2016-03-31 | Rs114.29 Billion ≈ $1.24 Billion |
+169.59% |
| 2015-03-31 | Rs42.40 Billion ≈ $458.49 Million |
+32.18% |
| 2014-03-31 | Rs32.08 Billion ≈ $346.88 Million |
-12.13% |
| 2013-03-31 | Rs36.50 Billion ≈ $394.76 Million |
-6.33% |
| 2012-03-31 | Rs38.97 Billion ≈ $421.45 Million |
+39.59% |
| 2011-03-31 | Rs27.92 Billion ≈ $301.92 Million |
+12.02% |
| 2010-03-31 | Rs24.92 Billion ≈ $269.52 Million |
-7.53% |
| 2009-03-31 | Rs26.95 Billion ≈ $291.46 Million |
+29.90% |
| 2008-03-31 | Rs20.75 Billion ≈ $224.37 Million |
+49.29% |
| 2007-03-31 | Rs13.90 Billion ≈ $150.29 Million |
-2.06% |
| 2006-03-31 | Rs14.19 Billion ≈ $153.45 Million |
+64.28% |
| 2005-03-31 | Rs8.64 Billion ≈ $93.40 Million |
+8.17% |
| 2004-03-31 | Rs7.98 Billion ≈ $86.35 Million |
-- |
About Lupin Limited
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutica… Read more